SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950131-00-005101
Filing Date
2000-08-28
Accepted
2000-08-28 00:00:00
Documents
13
Period of Report
2000-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ON FORM 10-K 0001.txt 10-K 359469
2 CERTIFICATE OF CHANGE 0002.txt EX-3.1(D) 1902
3 AMEND #3 TO SUPP EXECUTIVE RETIREMENT PLAN 0003.txt EX-10.4(D) 1692
4 AMEND TO MANGMNT INCENTIVE COMP PLAN 0004.txt EX-10.6(C) 7476
5 AMENDMENT TO RABBI TRUST 0005.txt EX-10.10(B) 5601
6 AMEND #1 TO MALLINCKRODT SEVERANCE PLAN 0006.txt EX-10.11(C) 1750
7 FORM OF AMENDED & RESTATED SEVERANCE AGREEMENT 0007.txt EX-10.12(A) 40763
8 RETENTION AGREEMENT 0008.txt EX-10.12(B) 36946
9 AMEND #1 TO EXECUTIVE INCENTIVE COMP PLAN 0009.txt EX-10.20(B) 5940
10 AMEND #2 TO EXECUTIVE INCENTIVE COMP PLAN 0010.txt EX-10.20(C) 4410
11 SUBSIDIARIES OF THE REGISTRANT 0011.txt EX-21 6538
12 CONSENT OF INDEPENDENT AUDITORS 0012.txt EX-23.1 1667
13 FINANCIAL DATA SCHEDULE 0013.txt EX-27 2283
  Complete submission text file 0000950131-00-005101.txt   479993
Mailing Address 675 MCDONNELL BLVD ST LOUIS MO 63134
Business Address 675 MCDONNELL BLVD PO BOX 5840 ST LOUIS MO 63134 3146542000
MALLINCKRODT INC /MO (Filer) CIK: 0000051396 (see all company filings)

IRS No.: 361263901 | State of Incorp.: NY | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-00483 | Film No.: 711111
SIC: 2835 In Vitro & In Vivo Diagnostic Substances